Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: Comparison of in vitro and animal models

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 2, 2003, Pages 353-359

  Tsuji, Masakatsu ^a,b   Matsuda, Hayato ^b   Miwa, Hideaki ^b   Miyazaki, Shuichi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Antibiotics; Carbapenems; Computerized simulation system; Lipopolysaccharide

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CYCLOPHOSPHAMIDE; DORIPENEM; ENDOTOXIN; LEAD ACETATE; MEROPENEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; COMPUTER SIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXPOSURE; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; CARBAPENEMS; CEFTAZIDIME; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; COMPUTER SIMULATION; ENDOTOXINS; FEMALE; LIPOPOLYSACCHARIDES; MICROSCOPY, PHASE-CONTRAST; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037326611     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg042     Document Type: Article

References (25)

1. Mock, C. N., Jurkovich, G. J., Dries, D. & Maier, R. V. (1996). The clinical significance of endotoxin released by antibiotics: what is the evidence? Journal of Endotoxin Research 3, 253-9.
2. Prins, J. M., van Agtmael, M. A., Kuijper, E. J., van Deventer, S. J. H. & Speelman, P. (1995). Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. Journal of Infectious Diseases 172, 886-91.
3. Hurley, J. C., Louis, W. J., Tosolini, F. A. & Carlin, J. B. (1991). Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrobial Agents and Chemotherapy 35, 2388-94.
4. McConnell, J. S. & Cohen, J. (1986). Release of endotoxin from Escherichia coli by quinolones. Journal of Antimicrobial Chemotherapy 18, 765-73.
5. Friedland, I. R., Jafari, H., Ehrett, S., Rinderknecht, S., Paris, M., Coulthard, M. et al. (1993). Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. Journal of Infectious Diseases 168, 657-62.
6. Eng, R. H. K., Smith, S. M., Fan-Havard, P. & Ogbara, T. (1993). Effect of antibiotics on endotoxin release from Gram-negative bacteria. Diagnostic Microbiology and Infectious Disease 16, 185-9.
7. Jackson, J. J. & Kropp, H. (1992). β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. Journal of Infectious Diseases 165, 1033-41.
8. Horii, T., Kobayashi, M., Sato, K., Ichiyama, S. & Ohta, M. (1998). An in vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of Gram-negative bacilli. Journal of Antimicrobial Chemotherapy 41, 435-42.
9. Tsuji, M., Ishii, Y., Ohno, A., Miyazaki, S. & Yamaguchi, K. (1998). In vitro and in vivo antibacterial activity of S-4661, a new carbapenem. Antimicrobial Agents and Chemotherapy 42, 94-9.
10. Japanese Society for Chemotherapy. (1981). Method for the determination of minimum inhibitory concentration (MIC) of fastidious and anaerobic bacteria by agar dilution method. Chemotherapy 29, 76-9.
11. Sasaki, S., Nishimura, K., Yoshida, I., Munekage, T., Imamura, N. & Ito, M. (1993). Study of an auto-simulation apparatus for evaluating bactericidal activity of antibiotics in human serum. Chemotherapy 41, 1056-63.
12. Selye, H., Tuchweber, B. & Bertok, L. (1966). Effect of lead acetate on the susceptibility of rats to bacterial endotoxins. Journal of Bacteriology 91, 884-90.
13. Kimura, Y., Nakano, M. & Yoshida, T. (1987). Microbiological assay methods for 6315-S (flomoxef) concentration in body fluid. Chemotherapy 35, Suppl. 1, 129-36.
14. Drusano, G. L., Standiford, H. C., Bustamante, C., Forrest, A., Rivera, G., Leslie, J. et al. (1984). Multiple-dose pharmacokinetics of imipenem-cilastatin. Antimicrobial Agents and Chemotherapy 26, 715-21.
15. Saito, A. (1992). Pharmacokinetics study on meropenem. Chemotherapy 40, Suppl. 1, 276-82.
16. Koyama, M., Nakagawa, K., Takeda, K., Higo, K. & Okumura, K. (1983). Phase-one clinical study on ceftazidime. Chemotherapy 31, Suppl. 3, 146-55.
17. Simpson, A. J., Opal, S. M., Angus, B. J., Prins, J. M., Palardy, J. E., Parejo, N. A. et al. (2000). Differential antibiotic-induced endotoxin release in severe melioidosis. Journal of Infectious Diseases 181, 1014-9.
18. Giamarellou-Bourboulis, E. J., Perdios, J., Lelekis, M., Eoconomou, E., Tsouroulas, P. & Giamarellou, H. (1999). Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFα) blood levels in patients suffering from acute pyelonephritis: a preliminary report. International Journal of Antimicrobial Agents 11, 115-9.
19. Maskin, B., Fontan, P. A., Spinedi, E. G., Gammella, D. & Badolati, A. (2002). Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia. Critical Care Medicine 30, 349-54.
20. Maury, E., Barakett, V., Blanchard, H., Guitton, C., Fitting, C., Vassal, T. et al. (1998). Circulating endotoxin during initial antibiotic treatment of severe gram-negative bacteremic infections. Journal of Infectious Diseases 178, 270-3.
21. Jackson, J. J. & Kropp, H. (1996). Differences in mode of action of β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy. Journal of Endotoxin Research 3, 201-18.
22. Hayes, M. V. & Orr, D. C. (1983). Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 12, 119-26.
23. Sumita, Y., Tada, E., Nouda, H., Okuda, T. & Fukusawa, M. (1992). Mode of action of meropenem, a new carbapenem antibiotic. Chemotherapy 40, Suppl. 1, 90-102.
24. Sunagawa, M., Matsumura, H., Inoue, T., Fukasawa, M. & Kato, M. (1990). A novel carbapenem antibiotic, SM-7338 structure-activity relationships. Journal of Antibiotics 43, 519-32.
25. Craig, W. A. (1998). Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26, 1-10.